Skip to main content

Systematic Literature Reviews for the Medical Device Industry

A Cost-Effective Way to Strengthen Your Product’s Evidence Base

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

MTRC has released a White Paper "General Market Access Landscape for Health Apps in Europe"

Our latest White Paper provides a structured overview of the reimbursement landscape for health apps in three major European countries: England, France, and Germany. It explores the administrative and regulatory frameworks, reimbursement mechanisms and health technology assessments available to digital health technologies across different care settings. Illustrative case studies on myCOPD, MyDiabby, and Vivira provide real-world examples of how health apps have navigated complex national systems to obtain reimbursement.

The publication outlines key insights such as:

  • The absence of a national reimbursement framework in England and the important role of local commissioners and NICE programs in app adoption;
  • The implementation of a structured reimbursement pathway via the LATM list in France, including brand-specific and generic registration options, and early access schemes for innovative technologies like PECAN;
  • The DiGA Fast-Track pathway in Germany offers a formal, evidence-based process for establishing reimbursement for health apps.

Read more and request a White Paper here.